Latest / Dayton News Today | 2 Min News | The Daily News Now!
FDA Approves New Pancreatic Cancer Pill | Dayton News
FDA just approved a groundbreaking daily pill, Rasonque, for adults with advanced pancreatic cancer — a disease long considered nearly untreatable. Targeting the RAS protein that fuels tumor growth, this drug offers patients who’ve exhausted other options a new lifeline. In a pivotal trial of 500 patients, those on Rasonque lived an average of 13 months — more than double those on standard chemo. The FDA fast-tracked approval by nearly seven months, underscoring urgency to deliver hope. Made by Revolution Medicines and already available via expanded access since May, it comes with side…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.